Financial News
Latest News about Healthy Returns
Recent news which mentions Healthy Returns
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
April 01, 2025
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
March 25, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: HHS Secretary RFK Jr. is making early moves that may affect vaccine access
February 25, 2025
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
From CNBC.com News
Healthy Returns: What to know about Trump's NIH funding cuts
February 12, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
January 21, 2025
From CNBC.com News
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
January 08, 2025
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
December 17, 2024
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
December 11, 2024
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
December 05, 2024
From CNBC.com News
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
November 26, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
November 13, 2024
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
October 31, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
